Gamifant approved in China for the treatment of primary haemophagocytic lymphohistiocytosis
Crwe World,
STOCKHOLM, March 18, 2022 /PRNewswire/ -- Sobi® today announced that the National Medical Products Administration of China (NMPA…
STOCKHOLM, March 18, 2022 /PRNewswire/ -- Sobi® today announced that the National Medical Products Administration of China (NMPA…
STOCKHOLM, March 18, 2022 /PRNewswire/ -- Sobi® today announced that the National Medical Products Administration of China (NMPA…
STOCKHOLM, March 18, 2022 /PRNewswire/ Sobi® today announced that the National Medical Products Administration of China (NMPA…